Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 11 OC58

ECE2006 Oral Communications ThyroidOC57 British Thyroid Association Award (8 abstracts)

Interleukin 1: the optimal cytokine target in thyroid associated ophthalmopathy?

TJ Cawood 1 , P Moriaty 3 , C O’Farrelly 4 & D O’Shea 2


1Education and Research Centre, St. Vincent’s University Hospital, Dublin, Ireland; 2Department of Endocrinology, St. Vincent’s University Hospital, Dublin, Ireland; 3Royal Victoria Eye and Ear Hospital, Dublin, Ireland; 4Conway Institute, University College Dublin, Dublin, Ireland.


Introduction: Anti-cytokine therapy may be useful for the treatment of active thyroid associated ophthalmopathy (TAO). We aimed to establish the effects of selected cytokines on intercellular adhesion molecule 1 (ICAM1) expression and adipogenesis in orbital fibroblasts (OFs) from patients with and without TAO.

Methods: Orbital tissue was taken during surgery from 5 patients with TAO and 5 control subjects. Primary cultures of OFs were established and stained for ICAM1 expression by flow cytometry. OFs were exposed to cytokines (TNFα, IL1, IFNγ, IL10 and TGFβ) and/or anti-cytokine agents (adalimumab, etanercept, infliximab and anakinra) and grown for 48 hours. The concentrations of anti-cytokine agents used were in the range of peak serum levels after therapeutic administration and also 1/100 of peak concentration. OFs were also cultured in adipogenic media in the presence of TNFα or IL1+/− their antagonists for 10 days, and adipogenesis measured by staining and extraction of oil-red-O, and by visual assessment.

Results: TNFα, IL1 and IFNγ (0.1 ng/ml) stimulated ICAM1 expression 8 to 10 fold in OFs from patients with TAO. Interleukin 10 (10 ng/ml) and TGFβ (1 ng/ml) had no effect. Similar responses were seen in OFs from control subjects. Anti-cytokine agents inhibited the ICAM1 responses to 0.1 ng/ml of TNFα or IL1 by 84% to 92% using peak concentrations and by 60% to 88% using 1/100 of peak concentrations (P values <0.01). IL1 stimulated adipogensesis (+42% and +400%) whilst TNFα inhibited adipogenesis (−41% and −100%), as measured by oil-red-O extraction and visual scoring, respectively (P values <0.05).

Conclusion: TNFα and IL1 have stimulatory effects on ICAM1 expression, but opposite effects on adipogenesis in orbital fibroblasts in vitro. Anti-TNFα agents have the potential to worsen TAO, particularly in patients where adipogenesis is prominent. Anti-IL1 agents may be the anti-cytokine agent of choice for clinical trials in active TAO.

Volume 11

8th European Congress of Endocrinology incorporating the British Endocrine Societies

European Society of Endocrinology 
British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.